The estimated Net Worth of Limited Partnership Medpace... is at least $2.75 Billion dollars as of 10 August 2018. Limited Medpace owns over 5,175,000 units of Medpace Inc stock worth over $1,748,127,246 and over the last 7 years Limited sold MEDP stock worth over $998,475,836.
Limited has made over 6 trades of the Medpace Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Limited sold 5,224,997 units of MEDP stock worth $286,068,586 on 27 August 2018.
The largest trade Limited's ever made was selling 5,224,997 units of Medpace Inc stock on 27 August 2018 worth over $286,068,586. On average, Limited trades about 3,833,333 units every 62 days since 2017. As of 10 August 2018 Limited still owns at least 5,224,997 units of Medpace Inc stock.
You can see the complete history of Limited Medpace stock trades at the bottom of the page.
Over the last 8 years, insiders at Medpace Inc have traded over $3,140,136,825 worth of Medpace Inc stock and bought 2,899,276 units worth $330,034,155 . The most active insiders traders include Limited Partnership Medpace..., August J. Troendle, and Investors, Llc Medpace. On average, Medpace Inc executives and independent directors trade stock every 9 days with the average trade being worth of $40,224,347. The most recent stock trade was executed by Robert O. Kraft on 22 August 2024, trading 8,127 units of MEDP stock currently worth $346,373.
a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
Medpace Inc executives and other stock owners filed with the SEC include: